Relay Therapeutics Inc

NASDAQ:RLAY  
52.06
-1.97 (-3.65%)
Other Pre-Announcement

Relay Therapeutics Reports Third Quarter 2020 Results

Published: 11/12/2020 21:38 GMT
(RLAY) - Relay Therapeutics Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $3.00.
Q3 Earnings per Share Estimate $-0.35 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Investments Totaled Approximately $713 Million As of September 30, 2020.
Expects Its Current Cash and Cash Equivalents Will Be Sufficient to Fund Its Current Operating Plan Into 2023.